{"id":309568,"date":"2019-12-12T17:58:16","date_gmt":"2019-12-13T01:58:16","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/zhejiang-medicine-and-ambrx-present-positive-top-line-data-from-a-phase-1a-1b-clinical-trial-of-arx788-in-metastatic-her2-positive-breast-cancer\/"},"modified":"2019-12-12T17:58:50","modified_gmt":"2019-12-13T01:58:50","slug":"%e6%b5%99%e6%b1%9f%e9%86%ab%e8%97%a5%e5%92%8c-ambrx-%e7%9a%84-arx788-%e8%87%a8%e5%ba%8a%e8%a9%a6%e9%a9%97%e7%8d%b2%e7%a9%8d%e6%a5%b5%e6%95%b8%e6%93%9a","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/%e6%b5%99%e6%b1%9f%e9%86%ab%e8%97%a5%e5%92%8c-ambrx-%e7%9a%84-arx788-%e8%87%a8%e5%ba%8a%e8%a9%a6%e9%a9%97%e7%8d%b2%e7%a9%8d%e6%a5%b5%e6%95%b8%e6%93%9a\/","title":{"rendered":"\u6d59\u6c5f\u91ab\u85e5\u548cAmbrx\u7684 ARX788\u81e8\u5e8a\u8a66\u9a57\u7372\u7a4d\u6975\u6578\u64da"},"content":{"rendered":"<p>\u6d59\u6c5f\u91ab\u85e5\u3001\u6d59\u6c5f\u65b0\u78bc\u751f\u7269\u548cAmbrx\u5728\u6b63\u5728\u9032\u884c\u7684\u201c 111\u201d\u8a66\u9a57\uff08CTR20171162\uff09\u4e2d\u5ba3\u4f48\u4e86\u7a4d\u6975\u4e2d\u671f\u6578\u64da\uff0c\u8a72\u8a66\u9a57\u8a55\u4f30\u4e86\u5728\u8f49\u79fb\u6027HER2\u967d\u6027\u4e73\u817a\u764c\u7684\u5927\u91cf\u9810\u8655\u7406\u60a3\u8005\u4e2d\u4f7f\u7528\u65b0\u578b\u6297HER2 ADC ARX788\u7684\u7642\u6548\u3002\u5165\u7d44\u7684\u6240\u6709\u60a3\u8005\u5148\u524d\u63a5\u53d7\u66f2\u59a5\u73e0\u55ae\u6297\u6cbb\u7642\u5931\u6557\uff0c47%\u63a5\u53d7\u66f2\u59a5\u73e0\u55ae\u6297\u548c\u62c9\u5e15\u66ff\u5c3c\u6cbb\u7642\u5931\u6557\u3002<\/p>\n<p>\u5728\u6240\u6709\u5291\u91cf\u6c34\u5e73\u4e0b\uff0cARX788\u5747\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u572851\u540d\u5165\u7d44\u60a3\u8005\u4e2d\u50c5\u89c0\u5bdf\u5230\u5169\u500b\u22653\u7d1a\u85e5\u7269\u76f8\u95dc\u7684\u53ef\u9006\u6027\u4e0d\u826f\u4e8b\u4ef6\u3002ARX788\u5728\u5291\u91cf\u4e0d\u65b7\u589e\u52a0\u6642\u4f9d\u7136\u5177\u6709\u51fa\u8272\u7684\u5b89\u5168\u6027\u3002<\/p>\n<p>\u53cd\u61c9\u7387\u8207\u5291\u91cf\u6c34\u5e73\u589e\u52a0\u76f8\u95dc\u3002\u622a\u81f3\u622a\u6b62\u65e5\u671f\uff0c\u6240\u6e2c\u8a66\u7684\u6700\u9ad8\u5291\u91cf\u70ba\u6bcf\u4e09\u54681.5\u6beb\u514b\/\u5343\u514b\u3002\u8a72\u4eba\u7fa4\u7e7c\u7e8c\u7d66\u85e5\u4e26\u4e00\u76f4\u8655\u65bc\u89c0\u5bdf\u4e4b\u4e2d\uff0c\u5df2\u7d93\u9054\u5230\u4e8663%\u7684\u7e3d\u9ad4\u7de9\u89e3\u7387\u3002\u5148\u524d\u7684\u968a\u5217\u7814\u7a76\u5206\u5225\u70ba0.88\u30011.1\u548c1.3 \u6beb\u514b\/\u5343\u514b\u5291\u91cf\uff0c\u7e3d\u9ad4\u7de9\u89e3\u7387\u5206\u5225\u70ba14%\uff0c36%\u548c56%\u3002\u6b64\u5916\uff0c\u50c5\u5728\u8f15\u5ea6\u589e\u52a0\u6bd2\u6027\u7684\u60c5\u6cc1\u4e0b\uff0c\u5c31\u53ef\u4ee5\u5728\u8f03\u9ad8\u5291\u91cf\u4e0b\u89c0\u5bdf\u5230\u7642\u6548\u7684\u5be6\u8cea\u6027\u63d0\u9ad8\u3002<\/p>\n<p>\u9019\u4e9b\u6578\u64da\u4f86\u81ea\u4e2d\u570b\u5fa9\u65e6\u5927\u5b78\u4e0a\u6d77\u764c\u75c7\u4e2d\u5fc3\uff0c\u9019\u662f\u66f4\u5ee3\u6cdb\u7684\u5168\u7403ARX788\u958b\u767c\u8a08\u5283\uff08NCT03255070\u548cCTR20171162\uff09\u7684\u4e00\u90e8\u5206\uff0c\u8a72\u8a08\u5283\u5305\u62ec\u5728\u4e2d\u570b\u3001\u7f8e\u570b\u548c\u6fb3\u5927\u5229\u4e9e\u7684\u81e8\u5e8a\u8a66\u9a57\u9ede\u3002<\/p>\n<p>\u6d59\u6c5f\u91ab\u85e5\u65bc2013\u5e74\u5728\u4e2d\u570b\u7372\u5f97\u4e86ARX788\u7684\u5546\u696d\u6388\u6b0a\u3002ARX788\u4ee4\u4eba\u9f13\u821e\u7684\u81e8\u5e8a\u6578\u64da\u70ba\u7b2c\u4e8c\u6b21\u53ca\u4ee5\u5f8c\u7684\u5408\u4f5c\u5960\u5b9a\u4e86\u5805\u5be6\u7684\u57fa\u790e\u3002\u4eca\u5e74\u65e9\u4e9b\u6642\u5019\uff0cAmbrx\u548c\u6d59\u6c5f\u91ab\u85e5\uff08\u901a\u904e\u5176\u5b50\u516c\u53f8\u6d59\u6c5f\u65b0\u78bc\u751f\u7269\uff09\u958b\u59cb\u4e86\u7b2c\u4e8c\u6b21\u5408\u4f5c\uff0c\u4ee5\u5728\u4e2d\u570b\u958b\u767c\u548c\u5546\u696d\u5316ARX305\u3002 ARX305\u662f\u4e00\u7a2e\u6297CD70\u6297\u9ad4\u85e5\u7269\u5076\u806f\u7269\uff0c\u7528\u65bc\u6f5b\u5728\u6cbb\u7642\u814e\u7d30\u80de\u764c\u3001\u591a\u767c\u6027\u9aa8\u9ad3\u7624\u548c\u5176\u4ed6\u5be6\u9ad4\u7624\u3002<\/p>\n<p>Ambrx Inc.\u662f\u4e00\u5bb6\u81e8\u5e8a\u968e\u6bb5\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u4f7f\u7528\u64f4\u5c55\u7684\u907a\u50b3\u5bc6\u78bc\u5275\u5efa\u540c\u985e\u6700\u4f73\u7684\u751f\u7269\u7642\u6cd5\uff0c\u5305\u62ec\u6297\u9ad4\u85e5\u7269\u5076\u806f\u7269\uff08ADC\uff09\u3001\u9776\u5411\u514d\u75ab\u8abf\u7bc0\u5291\u3001\u96d9\u7279\u7570\u6027\u6297\u9ad4\u548c\u5176\u4ed6\u5177\u6709\u6539\u5584\u7684\u85e5\u7406\u7279\u6027\u6216\u751f\u7269\u6d3b\u6027\u7684\u65b0\u578b\u751f\u7269\u88fd\u5291\u3002\u5229\u7528Ambrx\u5c08\u6709\u6280\u8853\u5e73\u81fa\uff0cAmbrx\u8207\u767e\u6642\u7f8e\u65bd\u8cb4\u5bf6\u516c\u53f8\u7b49\u5927\u578b\u4f01\u696d\u5408\u4f5c\u3002\u5728\u4e0d\u540c\u7684\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\u4f7f\u7528Ambrx\u6280\u8853\u751f\u7522\u85e5\u54c1\u3002Ambrx\u6b63\u5728\u63a8\u9032\u5f37\u5927\u7684\u5019\u9078\u7522\u54c1\u7d44\u5408\uff0c\u9019\u4e9b\u5019\u9078\u7522\u54c1\u91dd\u5c0d\u591a\u500b\u6cbb\u7642\u9818\u57df\u7684\u529f\u6548\u3001\u5b89\u5168\u6027\u548c\u6613\u7528\u6027\u9032\u884c\u4e86\u512a\u5316\u3002\u6709\u95dc\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f<a href=\"http:\/\/www.ambrx.com\/\">http:\/\/www.ambrx.com<\/a><\/p>\n<p>\u6d59\u6c5f\u91ab\u85e5\u80a1\u4efd\u6709\u9650\u516c\u53f8\uff08ZMC\uff09\u662f\u4e00\u5bb6\u5728\u4e0a\u6d77\u8b49\u5238\u4ea4\u6613\u6240\uff08SSE\uff03\uff1a600216\uff09\u4e0a\u5e02\u7684\u4e2d\u570b\u88fd\u85e5\u516c\u53f8\uff0c\u662f\u8102\u6eb6\u6027\u7dad\u751f\u7d20\u548c\u6297\u751f\u7d20\u7684\u5168\u7403\u9818\u5148\u88fd\u9020\u5546\uff0c\u76ee\u524d\u64c1\u67099\u500b\u5b50\u516c\u53f8\u548c2\u500b\u7814\u767c\u90e8\u9580\u3002\u6709\u95dc\u66f4\u591a\u4fe1\u606f\uff0c\u8acb\u8a2a\u554f<a href=\"http:\/\/www.china-zmc.com\/\">http:\/\/www.china-zmc.com<\/a><\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zhejiang Medicine, NovoCodex and Ambrx announced positive interim topline data from the ongoing &#8220;111&#8221; trial (CTR20171162) evaluating ARX788, a novel anti-HER2 ADC, in heavily pretreated patients with metastatic HER2 positive breast cancer.<\/p>\n","protected":false},"author":9,"featured_media":309561,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,564],"class_list":["post-309568","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=309568"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/309568\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/309561"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=309568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=309568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=309568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}